Ion AmpliSeq™ BRCA1 and BRCA2 Panel  Hide Panel Description

Description Mutations in tumor suppressor genes BRCA1 and BRCA2 have been implicated in hereditary breast and ovarian cancer. Much research is currently being done today to better detect, treat, and prevent cancer by assessing mutations in those who carry mutations in BRCA1 and BRCA2. The Ion AmpliSeq™ BRCA1/2 Panel utilizes 167 amplicons to analyze the coding regions of both BRCA1 and BRCA2. Design and validation is currently in progress with Drs. Marjolijn Ligtenberg and Arjen Mensenkamp from Radboud University Nijmegen Medical Centre, The Netherlands, and with Drs. José Carlos Machado and José Luis Costa from The Institute of Molecular Pathology and Immunology of the University of Porto.
  • Chip Calculator
  • 3 (30 ng)
  • Pools (Input DNA) Multiple Pools
  • Pool1: 55 amplicons | Pool2: 56 amplicons
    Pool3: 56 amplicons
  • 16.25 kb
  • Panel Size